These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 19141841

  • 21. Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.
    Wu SJ, Lee EM, Putvatana R, Shurtliff RN, Porter KR, Suharyono W, Watts DM, King CC, Murphy GS, Hayes CG, Romano JW.
    J Clin Microbiol; 2001 Aug; 39(8):2794-8. PubMed ID: 11473994
    [Abstract] [Full Text] [Related]

  • 22. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO, Lima DM, de Oliveira França RF, Gomes-Ruiz AC, da Fonseca BA.
    Arch Virol; 2008 Aug; 153(12):2215-23. PubMed ID: 19002647
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Imported cases of dengue virus infection: Emilia-Romagna, Italy, 2010.
    Pierro A, Varani S, Rossini G, Gaibani P, Cavrini F, Finarelli AC, Macini P, Cagarelli R, Mattivi A, Angelini P, Landini MP, Sambri V.
    Clin Microbiol Infect; 2011 Sep; 17(9):1349-52. PubMed ID: 21745260
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression.
    Biacchesi S, Skiadopoulos MH, Yang L, Murphy BR, Collins PL, Buchholz UJ.
    J Virol Methods; 2005 Sep; 128(1-2):192-7. PubMed ID: 15955576
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
    Alvarez Vera M, Valdés Palacios D, Vázquez Ramudo S, Delgado Hernández I, García Infante S, Morier Díaz L, Guzmán Tirado MG.
    Rev Cubana Med Trop; 1998 Sep; 50(3):177-81. PubMed ID: 10349439
    [Abstract] [Full Text] [Related]

  • 31. Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus.
    Schlesinger JJ, Chapman SE.
    Virology; 1999 Jul 20; 260(1):84-8. PubMed ID: 10405359
    [Abstract] [Full Text] [Related]

  • 32. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate.
    Liu CC, Wu SC.
    Biotechnol Bioeng; 2004 Mar 05; 85(5):482-8. PubMed ID: 14760688
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Development of a new neutralization test for measles virus.
    Fujino M, Yoshida N, Kimura K, Zhou J, Motegi Y, Komase K, Nakayama T.
    J Virol Methods; 2007 Jun 05; 142(1-2):15-20. PubMed ID: 17320979
    [Abstract] [Full Text] [Related]

  • 35. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD, Barrett AD.
    Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Investigation of West Nile virus seroprevalence in Hacettepe University Hospital blood donors and confirmation of the positive results by plaque reduction neutralization test].
    Ayturan S, Aydoğan S, Ergünay K, Ozcebe OI, Us D.
    Mikrobiyol Bul; 2011 Jan 30; 45(1):113-24. PubMed ID: 21341166
    [Abstract] [Full Text] [Related]

  • 38. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.
    Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PV.
    Vaccine; 2009 Apr 21; 27(18):2513-22. PubMed ID: 19368794
    [Abstract] [Full Text] [Related]

  • 39. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
    Goncalvez AP, Purcell RH, Lai CJ.
    J Virol; 2004 Dec 21; 78(23):12919-28. PubMed ID: 15542644
    [Abstract] [Full Text] [Related]

  • 40. High throughput quantitative colorimetric microneutralization assay for the confirmation and differentiation of West Nile Virus and St. Louis encephalitis virus.
    Taketa-Graham M, Powell Pereira JL, Baylis E, Cossen C, Oceguera L, Patiris P, Chiles R, Hanson CV, Forghani B.
    Am J Trop Med Hyg; 2010 Mar 21; 82(3):501-4. PubMed ID: 20207881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.